Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_75/2023, 11 October 2023)
| Date | 11 October 2023 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Central Division - Section |
| Type of action | Revocation Action |
| Case number(s) | UPC_CFI_75/2023 |
| Registry reference | ORD_579543/2023 · UPC_CFI_75/2023 |
| Parties | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. HELIOS K.K, RIKEN, OSAKA UNIVERSITY |
Official decision (PDF) · UPC registry entry
Case timeline
- 21 September 2023 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 September 2023) ORD_552745/2023 · UPC_CFI_75/2023
- 28 December 2023 : Mathys & Squire v Astellas (CFI, 28 December 2023) App_588681/2023 · UPC_CFI_75/2023
- 18 March 2024 : Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) ACT_464985/2023 · ORD_598255/2023 · UPC_CFI_75/2023
- 22 August 2024 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) App_588681/2023 · ORD_591107/2023 · UPC_CFI_75/2023
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By procedural order of 11 October 2023 (UPC_CFI_75/2023, ACT_464985/2023), the judge-rapporteur of the Munich section of the Central Division, in Astellas Institute for Regenerative Medicine’s revocation action against EP 3 056 563 held by Healios, Riken and Osaka University, ruled that the Defence to Revocation was deemed served on the claimant on 29 September 2023. The order confirms that the notification generated by the case management system (CMS) amounts to service, with no specific communication from the Court required.
Question
Was the Defence, first filed through the wrong CMS workflow and then refiled through the « Defence » workflow, served on the claimant in the absence of a separate communication from the Registry, and if so on what date?
Decision
The parties are in principle obliged to use the CMS and its dedicated workflows, and it is their sole responsibility to file properly and on time. Submissions and correspondence outside the CMS should be kept to a minimum. The notification generated by the system is the « means of electronic communication » referred to in Rule 278.1 RoP, and no further « specific communications » from the Court are required. The defendants argued that the two-month period for the Reply had not started for want of such communications. The claimant had said it would treat 29 September 2023, the date of refiling, as the date of service. As the defendants raised no objection to that date, the Court accepted it. A request for panel review remains available within 15 days (Rule 333 RoP).
Key points for practice
- Practical point: service of a pleading filed through the correct CMS workflow results from the system’s automatic notification, the period for reply runs without waiting for any step by the Registry, and filing through the wrong workflow may delay that starting point.
Provisions applied
- Rules of Procedure
- Rules 4.1, 6.1(b), 9, 32, 51, 271.6, 278.1, 278.4, 278.5 and 333
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Revocation action.
Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantRIKEN7 decisions in the corpusFollow this party
- claimantASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE10 decisions in the corpusFollow this party
- defendantOSAKA UNIVERSITY9 decisions in the corpusFollow this party
- defendantHELIOS K.K4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 21 September 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 September 2023) Revocation Action · UPC_CFI_75/2023
La demande d'accès d'un tiers au mémoire introductif et à la lettre de signification est rejetée : l'éducation et la formation ne sont pas un motif légitime, et la lettre n'est ni une écriture ni une pièce.
- 11 October 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_75/2023, 11 October 2023) Revocation Action · UPC_CFI_75/2023
- 28 December 2023 Mathys & Squire v Astellas (CFI, 28 December 2023) Application RoP262.1 (b) · UPC_CFI_75/2023
La demande d'accès de Mathys & Squire est mise en attente jusqu'à la décision de la cour d'appel sur la règle 262.1 b), à produire dans les trois semaines.
- 18 March 2024 Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) Revocation Action · UPC_CFI_75/2023
Le document D18 est admis sous réserve d'une réponse de la défenderesse avant le 11 avril 2024, la valeur du litige est fixée à 4 000 000 euros et l'audience confirmée au 25 juin 2024.
- 22 August 2024 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) Application RoP262.1 (b) · UPC_CFI_75/2023
Mathys & Squire obtient l'accès aux écritures et pièces de l'action en nullité close par transaction, après occultation des données personnelles et des informations confidentielles d'Astellas. L'appel est autorisé.
What the record states
- Nature of the act
- Revocation Action
- Outcome (Dhenne Avocats summary)
- Le mémoire en défense à l'action en nullité est réputé signifié le 29 septembre 2023, la notification générée par le CMS valant signification au sens de la règle 278.1.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 056 563mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) cited in this record
- Mathys & Squire v Astellas (CFI, 28 December 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 September 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_464985/2023, 16 June 2023) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 056 563Method of producing retinal pigment epithelial cell recorded proprietor: Healios KK, RIKEN et University of Osaka NUC | Mentioned in the analysis (role not qualified) Also mentioned in 7 other decision(s): Mathys & Squire v Astellas Institute for Regenerative Medicine (CFI, 4 · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 Au · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 23 Ju · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 M · Mathys & Squire v Astellas (CFI, 28 December 2023) · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 Se · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_ | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.